OneAscent Family Office’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$831K Buy
6,470
+2,288
+55% +$268K 0.42% 54
2026
Q1
$503K Buy
4,182
+174
+4% +$20.1K 0.35% 69
2025
Q4
$422K Buy
4,008
+658
+20% +$61.8K 0.29% 87
2025
Q3
$281K Buy
3,350
+253
+8% +$20.8K 0.23% 112
2025
Q2
$245K Buy
3,097
+311
+11% +$24.7K 0.23% 105
2025
Q1
$250K Buy
2,786
+262
+10% +$24.5K 0.23% 101
2024
Q4
$251K Buy
+2,524
New +$260K 0.46% 56

Other funds holding MRK

OneAscent Family Office's MRK Position: Q2 2026 in Review

OneAscent Family Office increased its Merck (MRK) stake by 55% in Q2 2026, buying an estimated $268K and bringing the position to 6,470 shares worth $831K. The position accounts for 0.42% of the portfolio, ranked #54.

OneAscent Family Office first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • OneAscent Family Office held 6,470 shares of Merck worth $831K as of Q2 2026.
  • OneAscent Family Office bought 2,288 Merck shares in Q2 2026, an estimated $268K.
  • Merck made up 0.42% of OneAscent Family Office's portfolio in Q2 2026, its #54 holding.
  • OneAscent Family Office first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on OneAscent Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.